Increased SLC38A4 Amino Acid Transporter Expression in Human Pancreatic α-Cells After Glucagon Receptor Inhibition
Authors:
Open Access
- 11 March 2019
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 160 (5) , 979-988
Abstract
Plasma amino acids and their transporters constitute an important part of the feedback loop between the liver and pancreatic α-cell function, and glucagon regulates hepatic amino acid turnover. Disruption of hepatic glucagon receptor action activates the loop and results in high plasma amino acids and hypersecretion of glucagon associated with α-cell hyperplasia. In the present study, we report a technique to rescue implanted human pancreatic islets from the mouse kidney capsule. Using this model, we have demonstrated that expression of the amino acid transporter SLC38A4 increases in α-cells after administration of a glucagon receptor blocking antibody. The increase in SLC38A4 expression and associated α-cell proliferation was dependent on mechanistic target of rapamycin pathway. We confirmed increased α-cell proliferation and expression of SLC38A4 in pancreas sections from patients with glucagon cell hyperplasia and neoplasia (GCHN) with loss-of-function mutations in the glucagon receptor. Collectively, using a technique to rescue implanted human islets from the kidney capsule in mice and pancreas sections from patients with GCHN, we found that expression of SLC38A4 was increased under conditions of disrupted glucagon receptor signaling. These data provide support for the existence of a liver–human α-cell endocrine feedback loop.Keywords
Funding Information
- Regeneron Pharmaceuticals
This publication has 18 references indexed in Scilit:
- Glucagon Cell Hyperplasia and Neoplasia With and Without Glucagon Receptor MutationsThe Journal of Clinical Endocrinology & Metabolism, 2015
- Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndromeWorld Journal of Gastrointestinal Surgery, 2015
- Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell HyperplasiaDiabetes, 2013
- Remodeling of Hepatic Metabolism and Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived PeptidesDiabetes, 2011
- Mice Deficient for Glucagon Gene-Derived Peptides Display Normoglycemia and Hyperplasia of Islet α-Cells But Not of Intestinal L-CellsMolecular Endocrinology, 2009
- Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell TumorPancreas, 2009
- Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout miceProceedings of the National Academy of Sciences, 2003
- Glucagon Replacement via Micro-Osmotic Pump Corrects Hypoglycemia and α-Cell Hyperplasia in Prohormone Convertase 2 Knockout MiceDiabetes, 2002
- Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.Journal of Clinical Investigation, 1980
- Glucagon Immunoreactivities and Amino Acid Profile in Plasma of Duodenopancreatectomized PatientsJournal of Clinical Investigation, 1979